Noro-Moseley Partners

An Atlanta-based private equity and venture capital firm founded in 1983 that targets early to growth-stage technology and healthcare companies in the United States, with a focus on the Southeast and Georgia. It invests across seed, startup, early and late venture, emerging growth and growth capital, and seeks to take board seats in portfolio companies. The firm focuses on software, information technology, internet security, cloud services, SaaS, data analytics, fintech and payment technologies, as well as healthcare infrastructure, health IT, revenue cycle management, telemedicine and care management platforms. It generally backs companies with roughly $2 million to $20 million in revenue and invests about $6 million to $10 million per deal. Noro-Moseley prefers opportunities headquartered in Georgia and nearby states such as Florida, North Carolina, Texas and others in the Southeast and beyond. It does not invest in pure drug development opportunities.

Ryan Collins

Principal

Michael Elliott

Venture Partner

William Hudson

CFO and Administrative Partner

Vasant Kamath

General Partner

Spence McClelland

General Partner

Past deals in Mississippi

Diabetes Care Group

Venture Round in 2012
Diabetes Care Group, Inc. is a healthcare provider specializing in diabetes clinical care services for individuals with diabetes and metabolic diseases. Founded in 1986 and based in Jackson, Mississippi, the company integrates a multidisciplinary approach that includes medical management, patient education, behavioral modification, and individualized nutrition counseling. Their services are designed to enhance patient self-management and improve clinical outcomes while also aiming to reduce overall medical and social costs associated with diabetes. The company employs a team of experienced professionals, including board-certified physicians, registered nurse educators, registered dieticians, and medical assistants, all dedicated to delivering effective diabetes care. Diabetes Care Group has established a track record of significant improvements in health outcomes for patients facing the challenges of diabetes.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.